PALB2 and ovarian cancer: Whereas the non-BRCA genes contribute 5/144 (3.47%) for hereditary breast and/or ovarian cancers; two mutations were detected in TP53 gene, and one mutation each was detected in PALB2, BRIP1, and ATM genes respectively.